CVS Health Corporation
CVS Health Corporation（CVS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CVS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
10
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
CVS Health Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CVS 季度内部人买卖趋势
CVS 内幕交易卖出 · CVS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CVS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CVS 高管卖出股份 · CVS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 31, 2026 | Newman Brian EVP, Chief Financial Officer | Other | 2,478 | $225K | Form 4 |
| May 31, 2026 | Compton-Phillips Amy EVP, Chief Medical Officer | Other | 7,618 | $693K | Form 4 |
| May 20, 2026 | AGUIRRE FERNANDO Director | Other | 30,437 | $2.85M⚡ | Form 4 |
| May 21, 2026 | AGUIRRE FERNANDO Director | Other | 1,563 | $146K | Form 4 |
| May 19, 2026 | ROBBINS LARRY Director | Sale | 1,983,387 | $187.33M⚡ | Form 4 |
| May 19, 2026 | ROBBINS LARRY Director | Sale | 151 | $14K | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 797,628 | $74.56M⚡ | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 152,691 | $14.48M⚡ | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 66,881 | $6.40M⚡ | Form 4 |
| May 20, 2026 | ROBBINS LARRY Director | Sale | 800 | $77K | Form 4 |
| May 21, 2026 | ROBBINS LARRY Director | Sale | 370,462 | $34.62M⚡ | Form 4 |
| May 14, 2026 | AGUIRRE FERNANDO Director | Award | 1,563 | $152K | Form 4 |
| May 14, 2026 | Balser Jeffrey R. Director | Award | 2,058 | $200K | Form 4 |
| May 14, 2026 | KIRBY J SCOTT Director | Award | 1,447 | $141K | Form 4 |
| May 14, 2026 | Norwalk Leslie V Director | Award | 1,447 | $141K | Form 4 |
| May 14, 2026 | SANSONE GUY P Director | Award | 1,447 | $141K | Form 4 |
| May 14, 2026 | BROWN C DAVID II Director | Award | 1,544 | $150K | Form 4 |
| May 8, 2026 | Mandadi Tilak EVP, Chief Exp & Tech Officer | Sale | 69,551 | $6.23M⚡ | Form 4 |
| Apr 1, 2026 | Shah Prem S EVP and Group President | Other | 1,484 | $108K | Form 4 |
| Apr 1, 2026 | Nelson Steven H EVP and President, Aetna | Other | 2,432 | $176K | Form 4 |
| Apr 1, 2026 | Mandadi Tilak EVP, Chief Exp & Tech Officer | Other | 3,634 | $263K | Form 4 |
| Apr 1, 2026 | Khichi Samrat S. EVP, CPO and General Counsel | Other | 3,541 | $257K | Form 4 |
| Apr 1, 2026 | Joyner J. David President, CEO and Chair · Director | Other | 8,029 | $582K | Form 4 |
| Apr 1, 2026 | Clark James David SVP, Cont & Chief Acct Officer | Other | 3,262 | $236K | Form 4 |
| Apr 1, 2026 | CAPOZZI HEIDI B EVP and Chief People Officer | Other | 1,334 | $97K | Form 4 |
Compton-Phillips Amy
EVP, Chief Medical Officer
日期
May 31
股数
7,618
均价
$90.98
总金额
$693K
Mandadi Tilak
EVP, Chief Exp & Tech Officer
日期
May 8
股数
69,551
均价
$89.58
总金额
$6.23M ⚡
Khichi Samrat S.
EVP, CPO and General Counsel
日期
Apr 1
股数
3,541
均价
$72.49
总金额
$257K
Joyner J. David
President, CEO and Chair · Director
日期
Apr 1
股数
8,029
均价
$72.49
总金额
$582K
Clark James David
SVP, Cont & Chief Acct Officer
日期
Apr 1
股数
3,262
均价
$72.49
总金额
$236K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CVS 内幕交易
CVS 内幕交易
CVS Health Corporation（CVS）内幕交易数据来源于公司内部人（包括ROBBINS LARRY (Director), AGUIRRE FERNANDO (Director), Mandadi Tilak (EVP, Chief Exp & Tech Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CVS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看CVS Health Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CVS 内幕交易 · 5个问题CVS Health Corporation（CVS）的内部人包括高管和董事，如ROBBINS LARRY (Director), AGUIRRE FERNANDO (Director), Mandadi Tilak (EVP, Chief Exp & Tech Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026